Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29)

Autor: Koeberle, D. ^*, Dufour, J.-F., Demeter, G., Li, Q., Ribi, K., Samaras, P., Saletti, P., Roth, A.D., Horber, D., Buehlmann, M., Wagner, A.D., Montemurro, M., Lakatos, G., Feilchenfeldt, J., Peck-Radosavljevic, M., Rauch, D., Tschanz, B., Bodoky, G.

Publikováno v: In Annals of Oncology May 2016 27(5):856-861

German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer.

Autor: Lordick F; Department of Medicine II (Oncology, Gastroenterology, Hepatology, and Pulmonology), University of Leipzig Medical Center, Liebigstr. 22, 04103, Leipzig, Germany. direktion.uccl@medizin.uni-leipzig.de., Al-Batran SE; Frankfurt, Institut Für Klinisch-Onkologische Forschung (IKF), UCT-Universitäres Centrum Für Tumorerkrankungen, Frankfurt, Germany., Arnold D; Asklepios Tumorzentrum Hamburg, Asklepios Klinik Altona, Hamburg, Germany., Borner M; ONCOCARE Am Engeriedspital, Berne, Switzerland., Bruns CJ; Universitätsklinikum Köln, Cologne, Germany., Eisterer W; Allgemein Öffentliches Klinikum, Klagenfurt am Wörthersee, Klagenfurt, Austria., Faber G; Celenus Teufelsbad Fachklinik, Blankenburg, Germany., Gockel I; Department of Medicine II (Oncology, Gastroenterology, Hepatology, and Pulmonology), University of Leipzig Medical Center, Liebigstr. 22, 04103, Leipzig, Germany., Köberle D; St.Claraspital, Basel, Switzerland., Lorenzen S; Klinikum Rechts der Isar, TU München, Munich, Germany., Möhler M; University Hospital Mainz, Mainz, Germany., Pritzkuleit R; Cancer Registry Schleswig-Holstein, Kiel, Germany., Stahl M; Evang. Huyssens-Stiftung Kliniken Essen-Mitte, Essen, Germany., Thuss-Patience P; Vivantes Klinikum Berlin-Friedrichshain, Berlin, Germany., Wöll E; St. Vinzenz-Klinikum, Zams, Austria., Zander T; Universitätsklinikum Köln, Cologne, Germany., Maschmeyer G; Deutsche Gesellschaft Für Hämatologie und Medizinische Onkologie, Berlin, Germany.

Publikováno v: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2024 Jan; Vol. 27 (1), pp. 6-18. Date of Electronic Publication: 2023 Oct 17.

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)

Autor: Ruhstaller, T. ^*, Widmer, L., Schuller, J.C., Roth, A., Hess, V., Mingrone, W., von Moos, R., Borner, M., Pestalozzi, B.C., BalmerMajno, S., Köberle, D., Terraciano, L., Schnider, A., Bodis, S., Popescu, R.

Publikováno v: In Annals of Oncology September 2009 20(9):1522-1528

PD-25 Disease characteristics and real-world treatment pathways of BRAF V600E-mutant metastatic colorectal cancer patients: Analysis of 120 patients enrolled in the BERING CRC study

Autor: Prager, G., Kisro, J., Müller-Huesmann, H., Heyde, E. von der, Stübs, P., Bürkle, D., Schmidt, B., Forstbauer, H., Hagemeyer, N., Reichenbach, F., Arnold, D., Fritsch, R., Gerger, A., Hegewisch-Becker, S., Vogel, A., Wagner, A., Winder, T., Koeberle, D., Stintzing, S.

Publikováno v: In Annals of Oncology June 2023 34 Supplement 1:S11-S11

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity

Autor: Borner, M.M. ^*, Bernhard, J., Dietrich, D., Popescu, R., Wernli, M., Saletti, P., Rauch, D., Herrmann, R., Koeberle, D., Honegger, H., Brauchli, P., Lanz, D., Roth, A.D.

Publikováno v: In Annals of Oncology February 2005 16(2):282-288